Package Leaflet: Information for the User

Copalia 5mg/80mg film-coated tablets

Copalia 5mg/160mg film-coated tablets

Copalia 10mg/160mg film-coated tablets

amlodipino/valsartán

Read this leaflet carefully before you start taking this medicine because it contains important information for you.

• Keep this leaflet, as you may need to read it again.
• If you have any doubts, consult your doctor or pharmacist.

-This medicine has been prescribed for you only, and you must not give it to others even if they have the same symptoms of disease as you, as it may harm them.

-If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet.See section4.

1.What isCopaliaand what it is used for

2.What you need to know before you start takingCopalia

3.How to takeCopalia

4.Possible side effects

5.Storage ofCopalia

6.Contents of the pack and additional information

Copaliatablets contain two substances called amlodipine and valsartan. Both substances help control high blood pressure.

• Amlodipine belongs to a group of substances called«calcium channel antagonists». Amlodipine prevents calcium from entering the blood vessel wall, which prevents blood vessel constriction.
• Valsartan belongs to a group of substances called«angiotensin II receptor antagonists». Angiotensin II is produced by the body and causes blood vessels to constrict, thereby increasing blood pressure. Valsartan acts by blocking the effect of angiotensin II.

This means that both substances help prevent blood vessel constriction. As a result, blood vessels relax and blood pressure decreases.

Copaliais used to treat high blood pressure in adults whose blood pressure is not adequately controlled with amlodipine or valsartan alone.

Do not take Copalia

• if you are allergic to amlodipine or any other calcium channel blocker. This may include symptoms such as itching, skin redness, or difficulty breathing.
• if you are allergic to valsartan or any of the other components of this medication (listed in section 6). If you think you may be allergic, inform your doctor before taking Copalia.
• if you have severe liver problems or bile duct problems such as biliary cirrhosis or cholestasis.
• if you are more than 3 months pregnant. (In any case, it is best to avoid taking this medication at the beginning of your pregnancy, see Pregnancy section).
• if you have severe low blood pressure (hypotension).
• if you have aortic stenosis (narrowing of the aortic valve) or cardiogenic shock (a condition in which your heart cannot supply enough blood to your body).
• if you have heart failure after a heart attack.
• if you have diabetes or kidney failure and are being treated with a blood pressure medication that contains aliskiren.

Do not take Copalia and inform your doctor if you are affected by any of the above cases.

Warnings and precautions

Consult your doctor before starting to take Copalia:

• if you have been sick (with vomiting or diarrhea).
• if you have liver or kidney problems.
• if you have had a kidney transplant or if you have been told that you have a narrowing of the kidney arteries.
• if you have a condition that affects your adrenal glands called "primary hyperaldosteronism".
• if you have had heart failure or have had a heart attack. Follow your doctor's instructions to start taking Copalia carefully. Your doctor may also check your kidney function.
• if your doctor has told you that you have a narrowing of the heart valves (called "aortic or mitral stenosis") or that your heart muscle has become abnormally thick (called "hypertrophic obstructive cardiomyopathy").
• if you have experienced swelling, particularly in the face and throat, while taking other medications (including ACE inhibitors). If you have these symptoms, stop taking Copalia and contact your doctor immediately. Never take Copalia again.
• if you experience abdominal pain, nausea, vomiting, or diarrhea after taking Copalia. Your doctor will decide whether to continue treatment. Do not stop taking Copalia on your own.
• if you are taking any of the following medications used to treat high blood pressure:
• an ACE inhibitor (such as enalapril, lisinopril, ramipril), particularly if you have kidney problems related to diabetes.
• aliskiren.

Your doctor may check your kidney function, blood pressure, and electrolyte levels (such as potassium) at regular intervals.

See also the information under the heading "Do not take Copalia".

Inform your doctor before taking Copalia if you are affected by any of the cases mentioned.

Children and adolescents

Copalia is not recommended for use in children or adolescents (under 18 years old).

Other medications and Copalia

Inform your doctor or pharmacist if you are using, have used recently, or may need to use any other medication. Your doctor may need to adjust your dose and/or take other precautions. In some cases, you may need to stop taking one of the medications. This applies especially to the medications listed below:

• an ACE inhibitor or aliskiren (see also the information under the headings "Do not take Copalia" and "Warnings and precautions");
• diuretics (a type of medication that increases urine production);
• lithium (a medication used to treat certain types of depression);
• potassium-sparing diuretics, potassium supplements, salt substitutes containing potassium, and other substances that may increase potassium levels;
• certain types of pain medications called nonsteroidal anti-inflammatory drugs (NSAIDs) or selective COX-2 inhibitors. Your doctor may also check your kidney function;

• anticonvulsants (e.g. carbamazepine, phenobarbital, phenytoin, fosphenytoin, primidone);
• St. John's Wort;
• nitroglycerin and other nitrates, or other substances called "vasodilators";
• medications used to treat HIV/AIDS (e.g. ritonavir, indinavir, nelfinavir);
• medications used to treat fungal infections (e.g. ketoconazole, itraconazole);
• medications used to treat bacterial infections (such as rifampicin, erythromycin, clarithromycin, telithromycin);
• verapamil, diltiazem (heart medications);
• simvastatin (a medication used to control high cholesterol levels);
• dantrolene (for severe temperature abnormalities);
• medications used to prevent rejection in a transplant (ciclosporin).

Taking Copalia with food and drinks

People taking Copalia should not consume grapefruit or grapefruit juice. This is because grapefruit and grapefruit juice may cause an increase in the blood levels of the active ingredient amlodipine, which may lead to unpredictable reductions in blood pressure.

Pregnancy and breastfeeding

Pregnancy

Inform your doctor if you are pregnant, if you suspect you may be pregnant, or if you plan to become pregnant.

Breastfeeding

Inform your doctor if you are planning to start or are breastfeeding. Amlodipine has been shown to pass into breast milk in small amounts.

It is not recommended to administer Copalia to women during this period. Your doctor may decide to administer a more suitable treatment if you want to breastfeed, especially for newborns or premature babies.

Consult your doctor or pharmacist before using any medication.

Driving and operating machinery

Copalia may cause dizziness, which may affect your ability to concentrate. If you are unsure how this medication will affect you, do not drive, operate machinery, or perform other activities that require concentration.

Follow exactly the administration instructions for this medication as indicated by your doctor. In case of doubt, consult your doctor again. This will help you obtain the best results and reduce the risk of adverse effects.

The usual dose ofCopaliais one tablet per day.

• It is preferable to take the medication at the same time every day.
• Swallow the tablets with a glass of water.
• You can takeCopaliawith or without food. Do not takeCopaliawith grapefruit or grapefruit juice.

Your doctor may suggest a higher or lower dose depending on your response to treatment.

Do not exceed the prescribed dose.

Copalia and Older Adults (65 years or older)

Your doctor should exercise caution when increasing the dose.

If you have any other questions about the use of this medication, ask your doctor or pharmacist.

If You Take More Copalia Than You Should

If you have taken too many tablets ofCopalia, or if someone else has taken your tablets, consult a doctor immediately.Excess fluid can accumulate in the lungs (pulmonary edema) causing breathing difficulty that may develop within 24-48hours after ingestion.

If You Forget to Take Copalia

If you forget to take this medication, take it as soon as you remember. Then take the next dose at the usual time. However, if it is almost time for the next dose, do not take the missed dose. Do not take a double dose to make up for the missed doses.

If You Discontinue Treatment with Copalia

Discontinuing your treatment withCopaliamay cause your condition to worsen. Do not stop taking your medication unless your doctor tells you to.

Like all medications,Copaliamay cause side effects, although not everyone will experience them.

Some side effects can be severe and require immediate medical attention:

A few patients have experienced these severe side effects.Notify your doctor if you notice any of the following:

the following, report to your doctor right away:

Rare (may affect up to 1 in 1,000 patients):allergic reaction with symptoms such as skin rash, itching, facial swelling, lip or tongue swelling, difficulty breathing, low blood pressure (dizziness, fainting).

Very rare (may affect up to 1 in 10,000 patients):intestinal angioedema: intestinal swelling accompanied by symptoms such as abdominal pain, nausea, vomiting, and diarrhea.

Other possible side effects of Copalia:

Frequent (may affect up to 1 in 10 patients):flu; stuffy nose, sore throat, and discomfort swallowing; headache; swelling in the arms, hands, legs, ankles, or feet; fatigue; asthenia (weakness); facial flushing and/or neck warmth.

Infrequent (may affect up to 1 in 100 patients):dizziness; nausea and abdominal pain; dry mouth; somnolence, paresthesia (tingling) or numbness of the hands or feet; vertigo, rapid heartbeat including palpitations; dizziness upon standing; cough; diarrhea; constipation; skin rash, skin redness; joint inflammation, back pain; joint pain.

Rare (may affect up to 1 in 1,000 patients):anxiety; tinnitus (ringing in the ears); fainting; increased urine production or urgent need to urinate; inability to achieve or maintain an erection; feeling of heaviness; low blood pressure with symptoms such as dizziness, fainting; excessive sweating; skin rash all over the body, itching, muscle spasms.

Notify your doctor if you are severely affected by any of the cases mentioned.

Side effects reported with amlodipine or valsartan alone and not observed with Copalia or observed with a higher frequency than with Copalia:

Amlodipine

Consult your doctor immediately if you experience any of the following severe side effects, which are very rare after taking this medication:

• sudden hissing sounds while breathing (sudden onset of bronchospasm), chest pain, shortness of breath, or difficulty breathing.
• swelling of the eyelids, face, or lips.
• swelling of the tongue and throat that causes severe difficulty breathing.
• severe skin reactions that include intense skin rash, blisters, widespread skin redness, severe itching, blistering, peeling, and inflammation of the skin, inflammation of the mucous membranes (Stevens-Johnson syndrome, toxic epidermal necrolysis) or other allergic reactions.
• heart attack, abnormal heartbeat.
• pancreatitis that can cause severe abdominal pain and back pain accompanied by a feeling of severe discomfort.

The following side effects have been reported. If any of these cause problems or last more than a week, consult your doctor.

Frequent (may affect up to 1 in 10 patients):dizziness, somnolence; palpitations (feeling the heartbeat); hot flashes, swelling of the ankles (edema); abdominal pain, feeling unwell (nausea).

Infrequent (may affect up to 1 in 100 patients):mood changes, anxiety, depression, somnolence, tremor, altered taste, fainting, loss of pain sensation; visual disturbances, visual deterioration, tinnitus; decreased blood pressure; nasal congestion and discharge caused by inflammation of the nasal mucosa (rhinitis); indigestion, vomiting (discomfort); hair loss, increased sweating, itching skin, skin discoloration; urinary disorders, increased need to urinate at night, increased frequency of urination; inability to achieve an erection, breast tenderness or enlargement in men, pain, discomfort, muscle pain, muscle cramps; weight gain or loss.

Rare (may affect up to 1 in 1,000 patients):confusion.

Very rare (may affect up to 1 in 10,000 patients):decreased white blood cell count, decreased platelet count that can cause easy bruising or unusual bruising (damage to red blood cells); hyperglycemia (excess glucose in the blood).

Valsartan

Unknown frequency (frequency cannot be estimated from available data):decreased red blood cell count, fever, sore throat or ulcers in the mouth due to infection; spontaneous bleeding or bruising; increased potassium in the blood; abnormal liver function test results; decreased kidney function and severely decreased kidney function; swelling, mainly of the face and throat; muscle pain; skin rash, red spots (purpura); fever; itching; allergic reaction, blistering skin disease (sign of a disease called dermatitis bullosa).

Notify your doctor if you experience any of the cases mentioned.

Notify your doctor or pharmacist if you experience any side effects, even if they are not listed in this prospectus.

Reporting of side effects

If you experienceany type of side effect, consult your doctor or pharmacist, even if it is apossibleside effect not listed in this prospectus.You can also report them directlythrough the national notification system included in theAnexo V. By reporting side effects, you can contribute to providing more information on the safety of this medication.

Keep this medication out of the sight and reach of children.

Do not use this medication after the expiration date that appears on the box and the blister pack.

Do not store at a temperature above30°C.

Store in the original packaging to protect it from moisture.

Do not useCopaliaif you observe that the packaging is damaged or shows signs of tampering.

Composition of Copalia

Copalia 5mg/80mg film-coated tablets

The active ingredients ofCopaliaare amlodipine (as amlodipine besylate) and valsartan. Each tablet contains5mg of amlodipine and 80mg of valsartan.

The other components are microcrystalline cellulose; crospovidone (type A); anhydrous colloidal silica; magnesium stearate; hypromellose(type of substitution 2910 (3 mPa.s)); macrogol 4000; talc, titanium dioxide (E171); yellow iron oxide (E172).

Copalia 5mg/160mg film-coated tablets

The active ingredients ofCopaliaare amlodipine (as amlodipine besylate) and valsartan. Each tablet contains 5mg of amlodipine and 160mg of valsartan.

The other components are microcrystalline cellulose, crospovidone (type A); anhydrous colloidal silica; magnesium stearate; hypromellose(type of substitution 2910 (3 mPa.s)); macrogol 4000; talc, titanium dioxide (E171); yellow iron oxide (E172).

Copalia 10mg/160mg film-coated tablets

The active ingredients ofCopaliaare amlodipine (as amlodipine besylate) and valsartan. Each tablet contains 10mg of amlodipine and 160mg of valsartan.

The other components are microcrystalline cellulose, crospovidone (type A), anhydrous colloidal silica; magnesium stearate; hypromellose(type of substitution 2910 (3 mPa.s)); macrogol 4000; talc, titanium dioxide (E171); yellow iron oxide (E172), red iron oxide (E172).

Appearance of the product and contents of the pack

Copalia5mg/80mg tablets are round and dark yellow in color with«NVR»on one side and«NV»on the other side.Approximate size: diameter 8.20mm.

Copalia5mg/160mg tablets are oval and dark yellow in color with«NVR»on one side and«ECE»on the other side.Approximate size::14.2mm (length) x 5.7mm (width).

Copalia10mg/160mg tablets are oval and light yellow in color with«NVR»on one side and«UIC»on the other side.Approximate size::14.2mm (length) x 5.7mm (width).

Copaliais available in packs containing 7, 14, 28, 30, 56, 90, 98 or 280tablets and in multiple packs containing 4boxes, each containing 70tablets, or 20boxes, each containing 14tablets.All packs are available with standard blisters; packs of 56, 98 and 280tablets are also available with perforated unit blisters.

Not all pack sizes may be marketed in your country.

Marketing Authorisation Holder

Novartis Europharm Limited

Vista Building

Elm Park, Merrion Road

Dublin 4

Irlanda

Responsible for manufacturing

Novartis Farma S.p.A.

Via Provinciale Schito 131

80058 Torre Annunziata (NA)

Italia

Novartis Farmacéutica SA

Gran Via de les Corts Catalanes, 764

08013 Barcelona

España

Novartis Pharma GmbH

Roonstraße 25

D-90429 Nuremberg

Alemania

Novartis Pharma GmbH

Sophie-Germain-Strasse 10

90443 Nürnberg

Alemania

For further information about this medicinal product, please contact the local representative of the marketing authorisation holder:

Last update of this summary of product characteristics:

Other sources of information

The detailed information on this medicinal product is available on the website of the European Medicines Agency:http://www.ema.europa.eu